Xue L, Zhou J, Tang W, Zhao W, et al. Intravenous amivantamab after cetuximab failure in recurrent or metastatic head and neck squamous cell carcinoma: a single-centre retrospective real-world cohort study. Oral Oncol 2026;180:108051.
PMID: 42284626